Comparison of tecar and laser compared to laser in patients with lumbar disc protrusion

Comparative Effect of High-power LASER with Tecar Therapy and High-power LASER in the Patients with Lumbar Discopathy: Randomized controlled trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20161221031506N7

Enrollment

Registered

2022-01-09

Start date

2022-02-20

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic, thoracolumbar, and lumbosacral intervertebral disc disorders. Thoracic, thoracolumbar, and lumbosacral intervertebral disc disorders

Interventions

Intervention 1: Intervention group: Apply TECAR therapy for 15 minutes.5 minutes of capacitive mode and 10 minutes of resistive mode is used in the area between the lower gear margin and PSIS with emp

Eligibility

Sex/Gender

All

Age

25 Years to 70 Years

Inclusion criteria

Inclusion criteria: Aged 25 to 70 years VAS greater than or equal to 4 Patients diagnosed with lumbar disc herniation with and without lower limb pain by computed tomography scan (CT SCAN) or MRI who have physiotherapy indications as prescribed by an Orthopedist, or rheumatologist.

Exclusion criteria

Exclusion criteria: Patients with spondylosis using MRI or CT scan Diagnosis of lumbar vertebrae fracture diagnosed by MRI or CT scan Patients with rheumatology or any other autoimmune disease Patients with severe osteoporosis Patients with tuberculosis or spinal tumors History of surgical indications History of sensory disturbance and vascular disorders History of implant and pacemaker History of disc surgery Severe sensitivity to light Contraindication to high-power LASER, TECAR Therapy, and electrotherapy

Design outcomes

Primary

Measure	Time frame
Disability using Ostwestry questionnaire score. Timepoint: Before and immediately after treatment. Method of measurement: Ostwestry Questionnaire.	—

Secondary

Measure	Time frame
Pain Using VAS. Timepoint: Before and immediately after treatment. Method of measurement: Visual Analogue scale.;Rolland Morris Score. Timepoint: Before and immediately after treatment. Method of measurement: Rolland-Morris Questionnaire.;Straight Leg Raising Angle. Timepoint: Before and immediately after treatment. Method of measurement: Straight Leg Raising.;Effectiveness of treatment using GRC Score. Timepoint: Immediately after treatment. Method of measurement: GRC Score.	—

Measure

Time frame

Pain Using VAS. Timepoint: Before and immediately after treatment. Method of measurement: Visual Analogue scale.;Rolland Morris Score. Timepoint: Before and immediately after treatment. Method of measurement: Rolland-Morris Questionnaire.;Straight Leg Raising Angle. Timepoint: Before and immediately after treatment. Method of measurement: Straight Leg Raising.;Effectiveness of treatment using GRC Score. Timepoint: Immediately after treatment. Method of measurement: GRC Score.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Davoudi

Mashhad University of Medical Sciences

rezadavoodi25@gmail.com+98 51 3846 0199

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026